The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

Share Price Information for Walker Crips (WCW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 23.00
Ask: 25.00
Change: 0.50 (2.13%)
Spread: 2.00 (8.696%)
Open: 23.50
High: 24.00
Low: 23.50
Prev. Close: 23.50
WCW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

21 Apr 2016 07:00

RNS Number : 8473V
Walker Crips Group plc
21 April 2016
 

21 April 2016

Walker Crips Group plc

Issue of Equity and Total Voting Rights

 

Further to its announcement of 9 March 2015 regarding the acquisition of Barker Poland Asset Management LLP ("BPAM"), Walker Crips Group plc ("Walker Crips" or the "Company"), the financial services group with activities including stockbroking, investment and wealth management, announces that an aggregate of 150,574 new ordinary shares in the capital of Company (the "Shares") have been issued and allotted to the Sellers of BPAM in order to satisfy the Company's obligations in connection with the payment of the year one BPAM deferred consideration. The BPAM business has met the targets required to trigger a payment by the Company of the full amount of the first of 3 potential payments of deferred consideration.

Under the terms of the agreement for the acquisition of BPAM, deferred consideration may become due in each of the first three years following completion, dependent on the results achieved by the legacy BPAM Business. All deferred consideration due under the agreement is payable 90% in cash and 10% in new ordinary shares in the Company. The cash element of the year one deferred consideration has been satisfied from the Company's existing cash resources.

Application is being made to the UK Listing Authority for the Shares to be admitted to the Official List, and application is being made to the London Stock Exchange for the Shares to be admitted to trading on its main market for listed securities. It is expected that such admission will become effective at 8.00 am on 25 April 2016 ("Admission").

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company notifies the market that following Admission, the Company's issued share capital will consist of 39,074,620 ordinary shares with a nominal value of 6 2/3 pence each ("Ordinary Shares") with each Ordinary Share carrying the right to one vote. The Company holds 750,000 Ordinary Shares in Treasury. Therefore, following Admission, the Company will have 38,324,620 Ordinary Shares in issue (excluding treasury shares) and, accordingly, the total number of voting rights in the Company will be 38,324,620.

The above figure 38,324,620 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Walker Crips Group plc under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information contact:

Walker Crips Group plc +44 (0) 20 3100 8000

Rodney FitzGerald, Chief Executive

Cantor Fitzgerald Europe   +44 (0) 20 7894 7667

Rishi Zaveri / Will Goode

Forward-Looking Statements

This Announcement contains (or may contain) certain forward-looking statements with respect to certain of the Company's current expectations and projections about future events. These statements, which sometimes use words such has "aim, "anticipate", "believe", "intend", "plan", "estimate", "expect" and words of a similar meaning, reflect the directors' beliefs and expectations and involve a number of risks, uncertainties and assumptions that could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statement. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Statements contained in this Announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The information contained in this Announcement is subject to change without notice and, except as required by applicable law, neither the Company, nor any member of its group, its Directors or its Financial Adviser assumes any responsibility or obligation to update publicly or review any of the forward-looking statements contained therein. Investors should not place undue reliance on forward-looking statements, which speak only as of the date of this Announcement. No statement in this Announcement is or is intended to be a profit forecast or to imply that the earnings of the Company for the current or future financial years will necessarily match or exceed the historical or published earnings of the Company.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESEMFWSFMSESL
Date   Source Headline
29th May 201912:01 pmRNSDirector/PDMR Shareholding
21st May 20195:15 pmRNSDirector/PDMR Shareholding
8th May 201911:30 amRNSDirector/PDMR Shareholding
27th Mar 20196:30 pmRNSDirector/PDMR Shareholding
13th Mar 20195:53 pmRNSReplacement Director/PDMR Shareholding
13th Mar 201912:53 pmRNSDirector/PDMR Shareholding
7th Mar 20194:52 pmRNSDirector/PDMR Shareholding
4th Mar 20198:44 amRNSDirector/PDMR Shareholding
1st Mar 20193:56 pmRNSDirector/PDMR Shareholding
26th Feb 20194:00 pmRNSTrading Update
12th Feb 20194:56 pmRNSDirector / PDMR Shareholdings
30th Jan 20197:00 amRNSBoard changes
17th Dec 201812:00 pmRNSDirector/PDMR Shareholding
27th Nov 20188:36 amRNSHalf-year Report - Replacement
27th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
29th Oct 201811:25 amRNSDirector/PDMR Shareholding
11th Oct 20182:53 pmRNSDirector/PDMR Shareholding
20th Sep 201811:10 amRNSDirector/PDMR Shareholding
14th Sep 20185:24 pmRNSDirector/PDMR Shareholding
5th Sep 20184:33 pmRNSResult of AGM
31st Jul 20184:08 pmRNSFinal Results
8th Jun 20183:28 pmRNSDirector/PDMR Shareholding
25th May 20187:00 amRNSIssue of Equity and Total Voting Rights
26th Apr 20188:20 amRNSHolding(s) in Company
18th Apr 20185:34 pmRNSDirector/PDMR Shareholding
21st Mar 20187:00 amRNSHolding(s) in Company
6th Mar 20185:36 pmRNSHolding(s) in Company
19th Feb 20183:30 pmRNSDirector/PDMR Shareholding
9th Feb 20184:55 pmRNSDirectorate Change
4th Jan 201810:10 amRNSDirector/PDMR Shareholding
21st Dec 201710:10 amRNSDirector/PDMR Shareholding
13th Dec 201712:31 pmRNSHolding(s) in Company
13th Dec 201712:30 pmRNSDirector / PDMR Shareholdings
11th Dec 20178:24 amRNSDirector/PDMR Shareholding
1st Dec 20175:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20177:00 amRNSHalf-year Report
13th Oct 20177:00 amRNSIssue of Equity and Total Voting Rights
6th Sep 20174:02 pmRNSResult of AGM
31st Aug 20177:00 amRNSBoard changes
18th Jul 20177:00 amRNSAnnual Financial Results
22nd May 20171:41 pmRNSDirector/PDMR Shareholding
12th May 20177:00 amRNSIssue of Equity and Total Voting Rights
24th Mar 20175:09 pmRNSDirectorate Change
15th Mar 20177:00 amRNSSale of Fund Management Contract
9th Mar 20175:53 pmRNSHolding(s) in Company
9th Mar 20175:52 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSIssue of Equity and Total Voting Rights
3rd Mar 20173:13 pmRNSForm 8.3 - Clinical Computing
3rd Mar 20173:11 pmRNSForm 8.3 - Clinical Computing re Ian Amiee
21st Dec 201612:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.